104 related articles for article (PubMed ID: 11746524)
1. Grb2 dominantly associates with dynamin II in human hepatocellular carcinoma HepG2 cells.
Yoon SY; Jeong MJ; Yoo J; Lee KI; Kwon BM; Lim DS; Lee CE; Park YM; Han MY
J Cell Biochem; 2001; 84(1):150-5. PubMed ID: 11746524
[TBL] [Abstract][Full Text] [Related]
2. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells.
Yoon SY; Koh WS; Lee MK; Park YM; Han MY
Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747
[TBL] [Abstract][Full Text] [Related]
3. Multiple Grb2-protein complexes in human cancer cells.
Sastry L; Cao T; King CR
Int J Cancer; 1997 Jan; 70(2):208-13. PubMed ID: 9009162
[TBL] [Abstract][Full Text] [Related]
4. A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment.
Ando A; Yonezawa K; Gout I; Nakata T; Ueda H; Hara K; Kitamura Y; Noda Y; Takenawa T; Hirokawa N
EMBO J; 1994 Jul; 13(13):3033-8. PubMed ID: 8039498
[TBL] [Abstract][Full Text] [Related]
5. Differential interactions of the growth factor receptor-bound protein 2 N-SH3 domain with son of sevenless and dynamin. Potential role in the Ras-dependent signaling pathway.
Vidal M; Montiel JL; Cussac D; Cornille F; Duchesne M; Parker F; Tocqué B; Roques BP; Garbay C
J Biol Chem; 1998 Feb; 273(9):5343-8. PubMed ID: 9478994
[TBL] [Abstract][Full Text] [Related]
6. The isoform-specific stretch of hSos1 defines a new Grb2-binding domain.
Zarich N; Oliva JL; Jorge R; Santos E; Rojas JM
Oncogene; 2000 Nov; 19(51):5872-83. PubMed ID: 11127818
[TBL] [Abstract][Full Text] [Related]
7. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
8. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
9. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
10. Requirement for the adapter protein GRB2 in EGF receptor endocytosis.
Wang Z; Moran MF
Science; 1996 Jun; 272(5270):1935-9. PubMed ID: 8658166
[TBL] [Abstract][Full Text] [Related]
11. Dynamin binds to SH3 domains of phospholipase C gamma and GRB-2.
Seedorf K; Kostka G; Lammers R; Bashkin P; Daly R; Burgess WH; van der Bliek AM; Schlessinger J; Ullrich A
J Biol Chem; 1994 Jun; 269(23):16009-14. PubMed ID: 8206897
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
13. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells.
Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
J Exp Med; 1996 Jan; 183(1):179-86. PubMed ID: 8551221
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.
Vidal M; Goudreau N; Cornille F; Cussac D; Gincel E; Garbay C
J Mol Biol; 1999 Jul; 290(3):717-30. PubMed ID: 10395825
[TBL] [Abstract][Full Text] [Related]
15. The intramolecular allostery of GRB2 governing its interaction with SOS1 is modulated by phosphotyrosine ligands.
Kazemein Jasemi NS; Herrmann C; Magdalena Estirado E; Gremer L; Willbold D; Brunsveld L; Dvorsky R; Ahmadian MR
Biochem J; 2021 Jul; 478(14):2793-2809. PubMed ID: 34232285
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of Ras signal transduction as antitumor agents.
Garbay C; Liu WQ; Vidal M; Roques BP
Biochem Pharmacol; 2000 Oct; 60(8):1165-9. PubMed ID: 11007954
[TBL] [Abstract][Full Text] [Related]
17. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Grb2-binding proteins in human platelets activated by Fc gamma RIIA cross-linking.
Robinson A; Gibbins J; Rodríguez-Liñares B; Finan PM; Wilson L; Kellie S; Findell P; Watson SP
Blood; 1996 Jul; 88(2):522-30. PubMed ID: 8695800
[TBL] [Abstract][Full Text] [Related]
19. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
20. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
den Hertog J; Hunter T
EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
